Acinic cell carcinoma overview

Jump to navigation Jump to search

Acinic cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acinic cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Surgery

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Acinic cell carcinoma overview On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acinic cell carcinoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acinic cell carcinoma overview

CDC on Acinic cell carcinoma overview

Acinic cell carcinoma overview in the news

Blogs on Acinic cell carcinoma overview

Directions to Hospitals Treating Acinic cell carcinoma

Risk calculators and risk factors for Acinic cell carcinoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Swathi Venkatesan, M.B.B.S.[2]

Overview

Acinic cell carcinoma (ACC) is a low-grade malignant salivary neoplasm that constitutes approximately 17% of primary salivary gland malignancies. In the head and neck region, the parotid gland is the predominant site of origin. This tumor is usually a low-grade, highly differentiated carcinoma. Women are usually more frequently diagnosed than men. There are many risk factors, including cigarette smoking, genetic predisposition, radioactive substances, viral infections, rubber manufacturing, plumbing equipment and some types of woodworking, as well as asbestos mining and exposure to nickel compounds. Patients typically present with a slowly enlarging mass in the parotid region, nausea, vomiting and digestion problems. Treatments include complete surgical resection, chemotherapy, and radiation therapy. [1]

Historical Perspective

  • ACC was referred to as an entity for the first time more than 50 years ago by Godwin et al
  • The “acinar” term is derived from Latin term “acinus”, which means a cluster of and looks like grapes branch
  • The histological appearance is quite similar to secretory parenchymatous cells.
  • Before discovering this disease, clinically Acinic Cell Carcinoma was unrecognized.
  • At the time after recognizing the disease, it thought to be the nature of the tumor is benign.
  • Afterward, it has been detected that the recurrence tendency of the tumor showed the possibility of the malignant nature of the tumor.
  • Later WHO (World Health Organization) re-classified as a “malignant carcinoma” with low-grade behavior (2, 3).

Pathophysiology

Features of acinic cell carcinoma on fine needle aspiration include stippled chromatin and granular cytoplasm.

Microscopic Pathology

  • Cytologic features of acinic cell carcinoma on fine needle aspiration:
  • Chromatin stippled.
  • Granular cytoplasm.
  • Sheets of cells/acinar formation.

Differential diagnosis

Acinic cell carcinoma should be differentiated from parotitis, parotid gland benign tumor and mucoepidermoid carcinoma.

Epidemiology and demographics

Acinic cell carcinoma can appear at any age however, it is common in children.

  • Acinic cell carcinoma appears in all age groups, but presents at a younger median age (approx. 52 years) than most other salivary gland cancers.
  • Occurrences in children are quite common.


Risk factors

Radiation exposure and positive family history are known risk factors for acinic cell carcinoma.


Clinical data has suggested that the development of acinic cell carcinoma is related to several factors.

  • Radiation exposure: Radiation treatment for the head and neck cancer increases the risk of developing salivary gland cancer. Workplace exposure to certain radioactive substances may also increase the risk of salivary gland cancer.
  • Family history: Some epidemiological data suggest that members of some families seem to have a higher than usual risk of developing salivary gland cancers.

Screening

Screening is not recommended for acinic cell carcinoma.

Natural history, prognosis and complications

Acinic cell carcinoma is a slow growing tumor and it may affect the facial nerve or other adjacent tissues depending on its location. Prognosis is most favorable when the parotid gland is involved. Acinic cell carcinoma is a slow growing tumor and it may affect the facial nerve or other adjacent tissues depending on its location. Prognosis is most favorable when the parotid gland is involved. Progression of acinic cell carcinoma is slow but it may involve adjacent tissues if not treated adequately. Acinic cell carcinoma can spread to adjacent organs and eventually be lethal if not intervened on time. The prognosis is more favorable when the tumor is in a major salivary gland; the parotid gland is most favorable, then the submandibular gland; the least favorable primary sites are the sublingual and minor salivary glands. Large bulky tumors or high-grade tumors carry a poorer prognosis and may best be treated by surgical resection combined with postoperative radiation therapy.[2] The prognosis depends on the following:[3][4]

History and symptoms

Acinic cell carcinoma commonly presents with a mass in the neck, difficulty in swallowing and persistent pain.

Early acinic cell carcinoma does not have any symptoms. As the tumor grows larger, people may notice one or more of the following symptoms:

  • A mass or lump in face, neck, or mouth area.
  • Persistent pain.
  • A newly noticed difference between the size and/or shape of the left and right sides of face or neck region.
  • Numbness in part of face.
  • New weakness of the muscles on one side of face.
  • Pain and difficulty in swallowing.

Other diseases may also present with similar symptoms.

Physical Examination

Physical examination of neck may reveal a firm swelling and tenderness.

Staging

Staging of acinic cell carcinoma depends on tumor size and location. In general, tumors of the major salivary glands are staged according to size, extraparenchymal extension, lymph node involvement (in parotid tumors, whether or not the facial nerve is involved), and presence of metastases. Tumors arising in the minor salivary glands are staged according to the anatomic site of origin (e.g., oral cavity and sinuses).

Clinical stage, particularly tumor size, may be the critical factor to determine the outcome of salivary gland cancer and may be more important than histologic grade. Diagnostic imaging studies may be used in staging. With excellent spatial resolution and superior soft tissue contrast, magnetic resonance imaging (MRI) offers advantages over computed tomographic scanning in the detection and localization of head and neck tumors. Overall, MRI is the preferred modality for evaluation of suspected neoplasms of the salivary glands.

Treatment

Patients with acinic cell carcinoma have many treatment options. The selection depends on the stage of the tumor. The options are surgery, radiation therapy, chemotherapy, or a combination of these methods.

  • Surgery: Surgery is usually the main form of treatment for resectable salivary gland cancers.
  • Radiation therapy: High-energy x-rays and other types of radiations are used to kill cancer cells from keep growing.
  • Chemotherapy: The treatment is to use drugs to stop the growth of cancer cells either by killing the cells or by stopping them from dividing.

Surgery

Surgery is usually the main form of treatment for resectable salivary gland cancers.Large bulky tumors or high-grade tumors carry a poorer prognosis and may best be treated by surgical resection combined with postoperative radiation therapy.[2]

Follow-up after treatment

Complications of surgical treatment for parotid neoplasms include facial nerve dysfunction and frey syndrome, also known as gustatory flushing or auriculotemporal syndrome.[6]Frey syndrome has been successfully treated with injections of botulinum toxin A.[7],[8]

References

  1. Al-Zaher N, Obeid A, Al-Salam S, Al-Kayyali BS (2009). "Acinic cell carcinoma of the salivary glands: a literature review". Hematol Oncol Stem Cell Ther. 2 (1): 259–64. PMID 20063555.
  2. 2.0 2.1 Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR (1996). "Management of minor salivary gland carcinomas". Int J Radiat Oncol Biol Phys. 35 (3): 443–54. PMID 8655366.
  3. Vander Poorten VL, Balm AJ, Hilgers FJ, Tan IB, Loftus-Coll BM, Keus RB; et al. (1999). "The development of a prognostic score for patients with parotid carcinoma". Cancer. 85 (9): 2057–67. PMID 10223248.
  4. Terhaard CH, Lubsen H, Van der Tweel I, Hilgers FJ, Eijkenboom WM, Marres HA; et al. (2004). "Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group". Head Neck. 26 (8): 681–92, discussion 692-3. doi:10.1002/hed.10400. PMID 15287035.
  5. Dermatology Atlas "mastocytoma" Check |url= value (help).
  6. Gooden E, Witterick IJ, Hacker D, Rosen IB, Freeman JL (2002). "Parotid gland tumours in 255 consecutive patients: Mount Sinai Hospital's quality assurance review". J Otolaryngol. 31 (6): 351–4. PMID 12593546.
  7. Naumann M, Zellner M, Toyka KV, Reiners K (1997). "Treatment of gustatory sweating with botulinum toxin". Ann Neurol. 42 (6): 973–5. doi:10.1002/ana.410420619. PMID 9403490.
  8. von Lindern JJ, Niederhagen B, Bergé S, Hägler G, Reich RH (2000). "Frey syndrome: treatment with type A botulinum toxin". Cancer. 89 (8): 1659–63. PMID 11042557.

Template:Epithelial neoplasms


Template:WikiDoc Sources